StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Thursday. The firm issued a hold rating on the stock.

Milestone Scientific Stock Performance

Shares of Milestone Scientific stock opened at $0.65 on Thursday. The firm has a market cap of $49.79 million, a PE ratio of -6.50 and a beta of 0.94. The business’s 50 day simple moving average is $0.65 and its 200 day simple moving average is $0.69. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.35.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. The company had revenue of $2.26 million during the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC bought a new stake in Milestone Scientific Inc. (NYSE:MLSS) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 27,936 shares of the company’s stock, valued at approximately $26,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.